{
    "root": "308be64f-e32f-b592-e063-6394a90a451b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sildenafil Citrate",
    "value": "20250317",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS",
            "code": "L11K75P92J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "POLYVINYL ALCOHOL",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "SILDENAFIL CITRATE",
            "code": "BW9B0ZE037",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_58987"
        }
    ],
    "indications": {
        "text": "sildenafil citrate indicated treatment erectile dysfunction .",
        "doid_entities": [
            {
                "text": "erectile dysfunction (DOID:1875)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1875"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "patients , recommended dose 50 mg taken , needed , approximately 1 hour sexual activity . however , sildenafil tablets may taken anywhere 30 minutes 4 hours sexual activity ( 2.1 ) based effectiveness toleration , may increase maximum 100 mg decrease 25 mg ( 2.1 ) maximum recommended dosing frequency per day ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "sildenafil tablets , usp supplied green , oval-shaped , beveled edge , biconvex , film-coated tablets containing sildenafil citrate equivalent nominally indicated amount sildenafil debossed obverse reverse sides follows : obverse 25mg reverse sc ndc 68071-3592-1 bottle 10 ndc 68071-3592-9 bottle 90 recommended storage : store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) . [ usp controlled room temperature . ]",
    "adverseReactions": "sildenafil tablets patients using nitric oxide donors , organic nitrates organic nitrites form . sildenafil citrate shown potentiate hypotensive effect nitrates ( 4.1 , 7.1 , 12.2 ) known hypersensitivity sildenafil component tablet ( 4.2 ) guanylate cyclase ( gc ) stimulators , riociguat ( 4.3 )",
    "indications_original": "Sildenafil citrate is indicated for the treatment of erectile dysfunction.",
    "contraindications_original": "For most patients, the recommended dose is 50 mg taken, as needed, approximately 1 hour before sexual activity. However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ( 2.1 ) Based on effectiveness and toleration, may increase to a maximum of 100 mg or decrease to 25 mg ( 2.1 ) Maximum recommended dosing frequency is once per day ( 2.1 )",
    "warningsAndPrecautions_original": "Sildenafil tablets, USP are supplied as green, oval-shaped, beveled edge, biconvex, film-coated tablets containing sildenafil citrate equivalent to the nominally indicated amount of sildenafil and debossed on the obverse and reverse sides as follows:\n                  \n                  Obverse\n                  25mg\n                  \n                  \n                  Reverse\n                  SC\n                  NDC 68071-3592-1\n                  Bottle of 10\n                  \n                  NDC 68071-3592-9\n                  Bottle of 90\n                  \n                  \n                  \n                  \n                  \n                  \n                  \n                     Recommended Storage:Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F). [See USP Controlled Room Temperature.]",
    "adverseReactions_original": "Administration of sildenafil tablets to patients using nitric oxide donors, such as organic nitrates or organic nitrites in any form. Sildenafil citrate was shown to potentiate the hypotensive effect of nitrates ( 4.1 , 7.1 , 12.2 ) Known hypersensitivity to sildenafil or any component of tablet ( 4.2 ) Administration with guanylate cyclase (GC) stimulators, such as riociguat ( 4.3 )",
    "drug": [
        {
            "name": "Sildenafil Citrate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_58987"
        }
    ]
}